Mictonorm Forte (Propiverine Hydrochloride)

Propiverine Hydrochloride is an antimuscarinic used to manage symptoms of overactive bladder.

• Overactive bladder: reduces urgency, frequency and episodes of urge incontinence.
• Urinary urgency: improves control of sudden urges to void.
• Urinary frequency: decreases the number of daytime voids.
• Urge incontinence: lessens involuntary leakage episodes.

• Propiverine Hydrochloride acts as a muscarinic receptor antagonist, primarily blocking M2 and M3 receptors in the detrusor smooth muscle of the bladder. By inhibiting these receptors, it reduces involuntary detrusor contractions, increases bladder capacity, and improves storage function, thereby alleviating symptoms of overactive bladder.

Propiverine Hydrochloride may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Dry mouth: reduced salivary secretion leading to a feeling of thirst.
• Constipation: slowed gastrointestinal motility.
• Blurred vision: temporary visual disturbance.
• Headache: mild to moderate pain.
• Dizziness: sensation of light‑headedness.
• Nausea: feeling of stomach upset.

Serious or Rare Side Effects

• Urinary retention: difficulty emptying the bladder.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Tachycardia: rapid heart rate.
• Hepatic dysfunction: abnormal liver enzymes or jaundice.

When prescribing Mictonorm Forte, clinicians should consider several safety factors.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: use with caution in patients with liver disease.
• Elderly patients: increased susceptibility to anticholinergic effects; start at the lowest effective dose.
• Concomitant glaucoma: may exacerbate intra‑ocular pressure.
• Pregnancy: safety category unknown; avoid unless clearly needed.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Propiverine Hydrochloride can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase propiverine plasma levels.
• Other anticholinergics (e.g., tricyclic antidepressants): may amplify anticholinergic side effects.
• P‑glycoprotein inhibitors (e.g., verapamil): may affect drug absorption.

Moderate Interactions (Monitor Closely)

• Diuretics: may increase urinary frequency.
• Antihistamines: additive anticholinergic burden.
• Beta‑agonists: potential impact on bladder smooth‑muscle tone.